11 research outputs found
High-dose dietary zinc oxide mitigates infection with transmissible gastroenteritis virus in piglets
Zinc (Zn) supplementation has been shown to reduce the incidence of diarrhea
and to protect animals from intestinal diseases, but the mechanisms of this
protective effect against virus infection in vivo have not yet been
elucidated. Transmissible gastroenteritis virus (TGEV) causes diarrhea in
piglets with an age-dependent decrease of severity. RESULTS: We used 60 weaned
piglets that were divided into three groups to evaluate the effect of
different Zn levels added to a conventional diet (50 mg Zn/kg diet, Znlow,
control group). The other groups received the diet supplemented with ZnO at
final concentrations of 150 mg Zn/kg diet (Znmed), or 2,500 mg/kg diet
(Znhigh). Oral challenge infection with TGEV was performed when the pigs had
been fed for 1 week with the respective diet. Half of the piglets of each
group were sacrificed at day 1 and 18 after challenge infection. Fecal
consistency was improved and body weights increased in the Znhigh group when
compared to the other groups, but no direct effect of Zn concentrations in the
diet on fecal TGEV shedding and mucosal immune responses was detectable.
However, in the Znhigh group, we found a prevention of villus atrophy and
decreased caspase-3-mediated apoptosis of jejunal epithelium. Furthermore,
pigs receiving high Zn diet showed a down-regulation of interferon (IFN)-α,
oligoadenylate synthetase (OAS), Zn transporter SLC39A4 (ZIP4), but up-
regulation of metallothionein-1 (MT1), as well as the Zn transporters SLC30A1
(ZnT1) and SLC30A5 (ZnT5). In addition, forskolin-induced chloride secretion
and epithelial resistance were controlled at a physiological level in the
Znhigh but not the other groups. Finally, in the Znhigh group, we documented
an earlier and higher systemic TGEV-specific serum antibody response.
CONCLUSIONS: These results suggest that high dietary Zn could provide enhanced
protection in the intestinal tract and stimulate the systemic humoral immune
response against TGEV infection
Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors
<p>Abstract</p> <p>Background</p> <p>Although features of variable differentiation in glioblastoma cell cultures have been reported, a comparative analysis of differentiation properties of normal neural GFAP positive progenitors, and those shown by glioblastoma cells, has not been performed.</p> <p>Methods</p> <p>Following methods were used to compare glioblastoma cells and GFAP+NNP (NHA): exposure to neural differentiation medium, exposure to adipogenic and osteogenic medium, western blot analysis, immunocytochemistry, single cell assay, BrdU incorporation assay. To characterize glioblastoma cells <it>EGFR </it>amplification analysis, LOH/MSI analysis, and <it>P53 </it>nucleotide sequence analysis were performed.</p> <p>Results</p> <p><it>In vitro </it>differentiation of cancer cells derived from eight glioblastomas was compared with GFAP-positive normal neural progenitors (GFAP+NNP). Prior to exposure to differentiation medium, both types of cells showed similar multilineage phenotype (CD44+/MAP2+/GFAP+/Vimentin+/Beta III-tubulin+/Fibronectin+) and were positive for SOX-2 and Nestin. In contrast to GFAP+NNP, an efficient differentiation arrest was observed in all cell lines isolated from glioblastomas. Nevertheless, a subpopulation of cells isolated from four glioblastomas differentiated after serum-starvation with varying efficiency into derivatives indistinguishable from the neural derivatives of GFAP+NNP. Moreover, the cells derived from a majority of glioblastomas (7 out of 8), as well as GFAP+NNP, showed features of mesenchymal differentiation when exposed to medium with serum.</p> <p>Conclusion</p> <p>Our results showed that stable co-expression of multilineage markers by glioblastoma cells resulted from differentiation arrest. According to our data up to 95% of glioblastoma cells can present <it>in vitro </it>multilineage phenotype. The mesenchymal differentiation of glioblastoma cells is advanced and similar to mesenchymal differentiation of normal neural progenitors GFAP+NNP.</p
Effect of deposition of carbon deposits on charge flow in EGR valve in CI engine
The exhaust gas recirculation (EGR) valve regulates the exhaust gas flow between the engine exhaust manifold and the inlet one. This allows the inlet air to warm up, improving fuel evaporation and reducing the combustion temperature of the charge. Such a valve reduces the number of harmful substances in the exhaust gas. The valve sticks when too much sediment builds on the walls of the exhaust system, especially during driving in urban conditions or when leaks in the vacuum or exhaust pipes occur. A faulty valve causes the engine to run unevenly at idle speed and under light loads. The defective EGR valve weakens the inlet manifold capacity, increases combustion, clogging of the particulate filter, damage to the lambda probe. A blocked EGR valve may lead to engine immobilization as a result of the operation of its computerized control system. A model of the EGR valve of a selected diesel engine was developed to determine the velocity distribution of the load flowing in it for different values of the degree of valve opening and the volume of deposits on the valve walls. The volume of accumulated carbon deposits on the walls of the EGR valve was measured using a real engine. Based on the recorded mileage of the vehicle, the assumed average speed of the car, and the driving style of the driver, the intensity of deposition of carbon particles on the walls was estimated
Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis
Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis
LG-26GERMLINE AND SOMATIC FGFR1 ABNORMALITIES IN DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
Recurrent mutations affecting the histone H3.3 residues Lys27 or indirectly Lys36 are frequent drivers of pediatric high-grade gliomas (over 30 % of HGGs). To identify additional driver mutations in HGGs, we investigated a cohort of 60 pediatric HGGs using whole-exome sequencing (WES) and compared them to 543 exomes from non-cancer control samples. We identified mutations in SETD2, a H3K36 trimethyltransferase, in 15 % of pediatric HGGs, a result that was genome-wide significant (FDR = 0.029). Most SETD2 alterations were truncating mutations. Sequencing the gene in this cohort and another validation cohort (123 gliomas from all ages and grades) showed SETD2 mutations to be specific to high-grade tumors affecting 15 % of pediatric HGGs (11/73) and 8 % of adult HGGs (5/65) while no SETD2 mutations were identified in low-grade diffuse gliomas (0/45). Furthermore, SETD2 mutations were mutually exclusive with H3F3A mutations in HGGs (P = 0.0492) while they partly overlapped with IDH1 mutations (4/14), and SETD2-mutant tumors were found exclusively in the cerebral hemispheres (P = 0.0055). SETD2 is the only H3K36 trimethyltransferase in humans, and SETD2-mutant tumors showed a substantial decrease in H3K36me3 levels (P < 0.001), indicating that the mutations are loss-of-function. These data suggest that loss-of-function SETD2 mutations occur in older children and young adults and are specific to HGG of the cerebral cortex, similar to the H3.3 G34R/V and IDH mutations. Taken together, our results suggest that mutations disrupting the histone code at H3K36, including H3.3 G34R/V, IDH1 and/or SETD2 mutations, are central to the genesis of hemispheric HGGs in older children and young adults. © 2013 The Author(s)
Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR
Embryonal tumors with multilayered rosettes (ETMRs) are rare, deadly pediatric brain tumors characterized by high-level amplification of the microRNA cluster C19MC. We performed integrated genetic and epigenetic analyses of 12 ETMR samples and identified, in all cases, C19MC fusions to TTYH1 driving expression of the microRNAs. ETMR tumors, cell lines and xenografts showed a specific DNA methylation pattern distinct from those of other tumors and normal tissues. We detected extreme overexpression of a previously uncharacterized isoform of DNMT3B originating at an alternative promoter that is active only in the first weeks of neural tube development. Transcriptional and immunohistochemical analyses suggest that C19MC-dependent DNMT3B deregulation is mediated by RBL2, a known repressor of DNMT3B. Transfection with individual C19MC microRNAs resulted in DNMT3B upregulation and RBL2 downregulation in cultured cells. Our data suggest a potential oncogenic re-engagement of an early developmental program in ETMR via epigenetic alteration mediated by an embryonic, brain-specific DNMT3B isoform
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Glioblastoma multiforme (GBM) is a lethal brain tumour in adults
and children. However, DNA copy number and gene expression
signatures indicate differences between adult and paediatric cases1–4.
To explore the genetic events underlying this distinction, we
sequenced the exomes of 48 paediatricGBMsamples.Somaticmutations
in the H3.3-ATRX-DAXX chromatin remodelling pathway
were identified in 44% of tumours (21/48). Recurrent mutations
in H3F3A, which encodes the replication-independent histone 3
variant H3.3, were observed in 31% of tumours, and led to amino
acid substitutions at two critical positions within the histone tail
(K27M, G34R/G34V) involved in key regulatory post-translational
modifications.Mutations inATRX (a-thalassaemia/mental retardation
syndrome X-linked)5 and DAXX (death-domain associated
protein), encoding two subunits of a chromatin remodelling
complex required for H3.3 incorporation at pericentric heterochromatin
and telomeres6,7, were identified in 31% of samples overall,
and in 100% of tumours harbouring a G34R or G34V H3.3 mutation.
Somatic TP53 mutations were identified in 54% of all cases,
and in 86% of samples with H3F3A and/or ATRX mutations.
Screening of a large cohort of gliomas of various grades and
histologies (n5784) showedH3F3A mutations to be specific toGBM
and highly prevalent in children and young adults. Furthermore,
the presence of H3F3A/ATRX-DAXX/TP53 mutations was
strongly associated with alternative lengthening of telomeres and
specific gene expression profiles. This is, to our knowledge, the first
report to highlight recurrent mutations in a regulatory histone in
humans, and our data suggest that defects of the chromatin architecture
underlie paediatric and young adult GBM pathogenesis
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable heterogeneity. We have recently identified recurrent H3F3A mutations affecting two critical amino acids (K27 and G34) of histone H3.3 in one-third of pediatric GBM. Here, we show that each H3F3A mutation defines an epigenetic subgroup of GBM with a distinct global methylation pattern, and that they are mutually exclusive with IDH1 mutations, which characterize a third mutation-defined subgroup. Three further epigenetic subgroups were enriched for hallmark genetic events of adult GBM and/or established transcriptomic signatures. We also demonstrate that the two H3F3A mutations give rise to GBMs in separate anatomic compartments, with differential regulation of transcription factors OLIG1, OLIG2, and FOXG1, possibly reflecting different cellular origins